Literature DB >> 3083733

Eosinophilic myositis and muscular sarcocystosis in the carcasses of slaughtered cattle and lambs.

R Jensen, A F Alexander, R R Dahlgren, W R Jolley, W C Marquardt, D E Flack, B W Bennett, M F Cox, C W Harris, G A Hoffmann.   

Abstract

Fifty-three bovine and 7 ovine carcasses condemned for having eosinophilic myositis were evaluated. Four (7.3%) of the bovine carcasses had a few, large local lesions in skeletal muscles (category A), and 49 (92.7%) of the bovine carcasses and 7 (100%) of the ovine carcasses had multiple, small, disseminated lesions in tongue, esophagus, heart, diaphragm, or skeletal muscles (category B). Tissue from carcasses of category B were evaluated for bacteria, viruses, selenium, and pathologic changes. Pathogenic bacteria and viruses were not isolated and selenium concentrations were normal. In category B, all carcasses had granulomas; of the 49 bovine carcasses and 7 ovine carcasses, 38 (77.6%) and 7 (100%), respectively, had one or more granulomas with opened dead sarcocysts. The data indicated that opened sarcocysts killed the host myocyte and adjacent myocytes and stroma, thereby initiating granuloma formation.

Entities:  

Mesh:

Year:  1986        PMID: 3083733

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Eosinophilic myositis/lymphadenitis in slaughter cattle.

Authors:  A Bundza; T E Feltmate
Journal:  Can Vet J       Date:  1989-06       Impact factor: 1.008

2.  Eosinophilic myositis in a slaughtered Korean native cattle.

Authors:  Sun Hee Do; Da Hee Jeong; Jae Yong Chung; Jin Kyu Park; Hai Jie Yang; Dong Wei Yuan; Kyu Shik Jeong
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

3.  Molecular detection of cattle Sarcocystis spp. in North-West Italy highlights their association with bovine eosinophilic myositis.

Authors:  Selene Rubiola; Tiziana Civera; Felice Panebianco; Davide Vercellino; Francesco Chiesa
Journal:  Parasit Vectors       Date:  2021-04-23       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.